A coalition of 18 pharma companies located in India, China, Bangladesh and South Africa that manufacture generic drugs have pledged to work together to accelerate access to millions of doses of new interventions for COVID-19 for low- and middle-income countries.
from The Hindu - National https://ift.tt/3knlLqS
0 comments:
Post a Comment